comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 23:03:50 - browse：51169

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Too many hospitalized Covid

focus

WSS

Alabama IVF ruling threatens families facing fatal genetic disease

Having children helps parents live longer, especially after age 80

New documents shed light on MD Anderson Cancer Institute feud

Latigo launches with $135 million for Vertex

6 phony surgeries that take placebo to the extreme

Congress must protect the remaining independent doctors

knowledge

comprehensive

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

He's a Nobel laureate. Critics say he was misleading on Covid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Wildfire smoke exposes gaps in outdoor worker protections

Latigo launches with $135 million for Vertex

Guidelines to prevent youth baseball injuries need more muscle

NIH study of ME/CFS points to clear biological hallmarks

In age of alternative facts, a scholarly course on calling out crap

Alabama hospital puts IVF treatments on hold

explore

Readout Newsletter: Amylyx, Aurinia, and IQVIA

6 phony surgeries that take placebo to the extreme

Alabama hospital puts IVF treatments on hold

Why Eli Lilly’s earnings didn’t quite live up to the hype

Ed Silverman on new gene therapies, biosimilars, coffee, and more

In utero gene editing: an explainer

focus

entertainment

Wikipedia

hotspot